Skip to main content
. 2022 Apr 5;10(4):849. doi: 10.3390/biomedicines10040849
AD Alzheimer’s disease
AHR aryl hydrocarbon receptor
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
BBB blood–brain barrier
EAARs excitatory amino acid receptors
EPSPs excitatory postsynaptic potentials
GABA α-aminobutyric acid
GPR 35 G-protein-coupled receptor 35
HD Huntington’s disease
5-HT2 5-hydroxy-triptamin-2 receptor
KYNA kynurenic acid
KYN kynurenine
KAT II kynurenine aminotransferase II enzyme
L-KYN L-kynurenine
LTP long-term potentiation
NMDA N-methyl-D-aspartate receptor
PD Parkinson’s disease
PFC prefrontal cortex
QUIN quinolinic acid
Trp Tryptophan